Onlikang announced that the company recently received the “Drug Registration Certificate” for loxoprofen sodium gel patch issued by the State Drug Administration. The approval number is valid until July 20, 2031, and is deemed to have passed the consistency evaluation. This drug is used for anti-inflammatory and analgesic diseases such as osteoarthritis. This certification will enrich the company's generic drug pipeline and enhance competitiveness. However, in addition to the company, 16 companies have been deemed to have passed the consistency evaluation. Market competition is fierce, and drug sales are affected by factors such as policies and the environment, so there is uncertainty.

Onlikang announced that the company recently received the “Drug Registration Certificate” for loxoprofen sodium gel patch issued by the State Drug Administration. The approval number is valid until July 20, 2031, and is deemed to have passed the consistency evaluation. This drug is used for anti-inflammatory and analgesic diseases such as osteoarthritis. This certification will enrich the company's generic drug pipeline and enhance competitiveness. However, in addition to the company, 16 companies have been deemed to have passed the consistency evaluation. Market competition is fierce, and drug sales are affected by factors such as policies and the environment, so there is uncertainty.